Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 75, Issue 4, Pages 689-713Publisher
SPRINGER BASEL AG
DOI: 10.1007/s00018-017-2686-7
Keywords
Crosstalk; Immunotherapy; Immune escape; T cell exhaustion; Neoantigen; Oncolytic virotherapy; Cancer vaccine; Immune response; Clinical study; Cancer mouse model
Categories
Funding
- Deutsche Forschungsgemeinschaft [WO 1933/1-2] Funding Source: Medline
Ask authors/readers for more resources
The outstanding clinical success of immune checkpoint blockade has revived the interest in underlying mechanisms of the immune system that are capable of eliminating tumors even in advanced stages. In this scenario, CD4 and CD8 T cell responses are part of the cancer immune cycle and both populations significantly influence the clinical outcome. In general, the immune system has evolved several mechanisms to protect the host against cancer. Each of them has to be undermined or evaded during cancer development to enable tumor outgrowth. In this review, we give an overview of T lymphocyte-driven control of tumor growth and discuss the involved tumor-suppressive mechanisms of the immune system, such as senescence surveillance, cancer immunosurveillance, and cancer immunoediting with respect to recent clinical developments of immunotherapies. The main focus is on the currently existing knowledge about the CD4 and CD8 T lymphocyte interplay that mediates the control of tumor growth.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available